Organization · Venture Capital
Finchley Healthcare Ventures
Finchley Healthcare Ventures is a Canadian venture capital fund focused on investing in emerging companies within the life sciences sector, particularly those developing innovative drug therapies. The firm collaborates globally with scientists and entrepreneurs to address significant unmet medical needs.
Overview
What Finchley Healthcare Ventures does
What Finchley Healthcare Ventures is
Finchley Healthcare Ventures is a Canadian venture capital fund focused on investing in emerging companies within the life sciences sector, particularly those developing innovative drug therapies. The firm collaborates globally with scientists and entrepreneurs to address significant unmet medical needs.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find Finchley Healthcare Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Finchley Healthcare Ventures as a funder
Investment thesis
Finchley Healthcare Ventures invests in emerging therapeutic companies with novel approaches to inadequately treated diseases and a path to human proof of concept. The firm is modality-flexible, focusing on small molecules, antibodies, and breakthrough technologies.
Focus narrative
The organization invests in companies engaged in the development of innovative drug therapies, particularly those demonstrating proof of concept in humans. Finchley is interested in a wide range of diseases inadequately addressed by current therapies and seeks to support companies at various stages of development, from those about to start their first clinical trials to those further along in their research.
Value beyond capital
Finchley Healthcare Ventures provides more than just capital; it offers access to Pharmascience-related expertise in pharmaceutical R&D, manufacturing, commercialization, bioanalytics, and CDMO capabilities, enhancing the potential for portfolio companies to succeed in the competitive life sciences landscape.
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B
- Regions
- Global · North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 9
Portfolio context
Notable portfolio companies include: Triana Biomedicines Cartography Biosciences Capstan Therapeutics - participated in its US$175M Series B financing. Reverb Therapeutics - participated in its US$12M seed financing. Omega Funds Sofinnova Investments New Rhein CTI Life Sciences Fund Amplitude Ventures
Common questions
What to know about Finchley Healthcare Ventures
Upseed classifies Finchley Healthcare Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.